Clinical Trial Update: Clopidogrel Proton-Pump Inhibitors Study [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating the interaction between clopidogrel and proton-pump inhibitors has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• CLOPIDOGREL (CLOPIDOGREL)
• Proton Pump Inhibitors

Snippet

Sponsor: Sheba Medical Center | Conditions: Coronary Artery Disease | Phase 4 | Status: WITHDRAWN